Dr Richard Lipscombe, Managing Director of Proteomics International (ASX:PIQ), spoke with 2GB’s...
Early Oesophageal Cancer Diagnosis Now Closer for At-Risk – Mirage News
Proteomics International Laboratories’ blood test uses biomarkers to diagnose oesophageal adenocarcinoma and the pre-malignant condition, Barrett’s oesophagus, to detect the disease sooner and potentially improving health outcomes.
Article: Early Oesophageal Cancer Diagnosis Now Closer for At-Risk